ReviewWiener medizinische Wochenschrift (1946)2026
Avicenna's approach to the treatment of rabies in the perspective of current medicine.
Review in Wiener medizinische Wochenschrift (1946), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The current study explores Avicenna's approach to rabies management, which is documented in his seminal work, The Canon of Medicine. His diagnostic strategies, therapeutic principles, and suggested medicinal plants against rabies are elucidated. Moreover, we use the current literature to shed light on the extent of alignment of Avicenna's views and therapies with contemporary medical practice. Some parts of his views, such as the emphasis on wound hygiene and the use of herbal compounds with antiviral and immunomodulatory properties, are in agreement with modern knowledge. Our study summarizes the up-to-date knowledge of the historical recommendations that could be leveraged for new anti-rabies therapeutic options. Pharmacological features of phytochemicals and their potential applications are described. Further studies are necessary to evaluate the efficacy and safety of Avicenna's proposed treatments and their potential usability, for example as adjuvant therapeutic strategies in anti-rabies management.
Indexed as
Identifiers
40658151What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.